PTC Therapeutics (United States)

PTC Therapeutics (United States)

PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control mechanisms in orphan diseases. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for PTC Therapeutics (United States), United States, covering academic research published from 2000 to 2024. Read More.


Open Access Percentage

50%


Total
Publications

416


Total Open
Publications

210


Total
Citations

12K


Open Access
Percentage

50%


Total
Publications

416


Total Open
Publications

210


Total
Citations

12K

Wikipedia

Website

download

Breakdown

15% 27% 9% 49%

Publisher Open

15%

Both

27%

Other Platform Open

9%

Closed

49%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

051015202530354045Total Publications
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

27%OA Journal

OA Journal 27%

46

Hybrid 50%

87

No Guarantees 23%

39

Other Platform Open

Domain 87%

129

Institution 16%

24

Other Internet 13%

19

Public 10%

15

Preprint 7%

11

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
130
Europe PMC
Domain
65
University College London - UCL Discovery
Institution
19
DOI
Other Internet
14
Semantic Scholar
Public
9
Figshare
Public
9
California Digital Library - eScholarship
Other Internet
8
bioRxiv
Preprint
8
University of Massachusetts Medical School - eScholarship@UMMS
Institution
5
University of California - eScholarship University of California
Institution
5
1 / 3

Data updated 7 April 2025

Share

Share

Share